These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21114996)

  • 1. Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats.
    Li JT; Su YA; Guo CM; Feng Y; Yang Y; Huang RH; Si TM
    Eur J Pharmacol; 2011 Feb; 652(1-3):65-72. PubMed ID: 21114996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the cognition impairer MK-801 on learning and memory in mice and rats.
    van der Staay FJ; Rutten K; Erb C; Blokland A
    Behav Brain Res; 2011 Jun; 220(1):215-29. PubMed ID: 21310186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris water maze reveals differences between Long-Evans and Wistar rats.
    Vales K; Bubenikova-Valesova V; Klement D; Stuchlik A
    Neurosci Res; 2006 Aug; 55(4):383-8. PubMed ID: 16712995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
    Karasawa J; Hashimoto K; Chaki S
    Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
    Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
    Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subchronic MK-801 behavioural deficits in rats: partial reversal by the novel nitrate GT 1061.
    Beninger RJ; Forsyth JK; Van Adel M; Reynolds JN; Boegman RJ; Jhamandas K
    Pharmacol Biochem Behav; 2009 Feb; 91(4):495-502. PubMed ID: 18834899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
    Enomoto T; Ishibashi T; Tokuda K; Ishiyama T; Toma S; Ito A
    Behav Brain Res; 2008 Jan; 186(2):197-207. PubMed ID: 17881065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttraining injections of MK-801 produce a time-dependent impairment of memory in two water maze tasks.
    Packard MG; Teather LA
    Neurobiol Learn Mem; 1997 Jul; 68(1):42-50. PubMed ID: 9195588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W; Czyrak A; Wedzony K
    Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine ameliorates spatial memory deficits induced by MK-801 infusion into ventral hippocampus as evaluated by radial maze task in rats.
    Xu LS; Yang LX; Hu WW; Yu X; Ma L; Liu LY; Wei EQ; Chen Z
    Acta Pharmacol Sin; 2005 Dec; 26(12):1448-53. PubMed ID: 16297342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
    Pichat P; Bergis OE; Terranova JP; Urani A; Duarte C; Santucci V; Gueudet C; Voltz C; Steinberg R; Stemmelin J; Oury-Donat F; Avenet P; Griebel G; Scatton B
    Neuropsychopharmacology; 2007 Jan; 32(1):17-34. PubMed ID: 16936709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The investigation of neonatal MK-801 administration and physical environmental enrichment on emotional and cognitive functions in adult Balb/c mice.
    Akillioglu K; Babar Melik E; Melik E; Kocahan S
    Pharmacol Biochem Behav; 2012 Sep; 102(3):407-14. PubMed ID: 22704977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
    de Bruin NM; Prickaerts J; Lange JH; Akkerman S; Andriambeloson E; de Haan M; Wijnen J; van Drimmelen M; Hissink E; Heijink L; Kruse CG
    Neurobiol Learn Mem; 2010 May; 93(4):522-31. PubMed ID: 20132903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
    Stuchlík A; Vales K
    Behav Brain Res; 2005 Apr; 159(1):163-71. PubMed ID: 15795010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two learning tasks provide evidence for disrupted behavioural flexibility in an animal model of schizophrenia-like behaviour induced by acute MK-801: a dose-response study.
    Lobellova V; Entlerova M; Svojanovska B; Hatalova H; Prokopova I; Petrasek T; Vales K; Kubik S; Fajnerova I; Stuchlik A
    Behav Brain Res; 2013 Jun; 246():55-62. PubMed ID: 23499708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated treatment with N-methyl-d-aspartate antagonists in neonatal, but not adult, rats causes long-term deficits of radial-arm maze learning.
    Kawabe K; Iwasaki T; Ichitani Y
    Brain Res; 2007 Sep; 1169():77-86. PubMed ID: 17706184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks.
    Pitkänen M; Sirviö J; MacDonald E; Niemi S; Ekonsalo T; Riekkinen P
    Eur Neuropsychopharmacol; 1995 Dec; 5(4):457-63. PubMed ID: 8998397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a novel Active Allothetic Place Avoidance task (AAPA) in testing a pharmacological model of psychosis in rats: comparison with the Morris Water Maze.
    Stuchlik A; Rezacova L; Vales K; Bubenikova V; Kubik S
    Neurosci Lett; 2004 Aug; 366(2):162-6. PubMed ID: 15276239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model.
    Hsieh MH; Gu SL; Ho SC; Pawlak CR; Lin CL; Ho YJ; Lai TJ; Wu FY
    Behav Brain Res; 2012 Apr; 229(1):41-7. PubMed ID: 22227506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neonatal repeated MK-801 treatment on delayed nonmatching-to-position responses in rats.
    Kawabe K; Miyamoto E
    Neuroreport; 2008 Jun; 19(9):969-73. PubMed ID: 18521003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.